NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

ABIONYX Pharma SA (PA: ABNX)

 
ABNX Technical Analysis
5
As on 9th Jun 2023 ABNX STOCK Price closed @ 1.23 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.96 & Strong Sell for SHORT-TERM with Stoploss of 2.26 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ABNXSTOCK Price

Open 1.27 Change Price %
High 1.27 1 Day -0.04 -3.15
Low 1.20 1 Week -0.03 -2.38
Close 1.23 1 Month -0.59 -32.42
Volume 130520 1 Year -1.21 -49.59
52 Week High 2.98 | 52 Week Low 1.22
 
PA France Most Active Stocks
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ALDRV 0.01 0.00%
AF 1.73 1.76%
CGG 0.69 -2.82%
ALVMG 0.50 0.00%
ACA 10.83 -0.91%
ALJXR 0.01 0.00%
CS 26.52 -2.00%
GLE 23.32 1.92%
 
PA France Top Gainers Stocks
ALAGP 5.50 13.40%
ALSEN 0.32 10.34%
MLPAP 0.55 10.00%
ALMAR 1.15 9.52%
CO 6.03 8.84%
CO 6.03 8.84%
CO 6.03 8.84%
ALGAU 1.92 8.47%
2MX 7.46 8.43%
ATA 0.13 8.33%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
MLWEL 0.23 -28.12%
ALPHA 0.08 -27.27%
ALPHA 0.08 -27.27%
MLCLP 4.48 -25.95%
ALHYG 0.05 -16.67%
ALLIX 10.80 -13.60%
MLERO 2.52 -12.50%
 
 
ABNX
Daily Charts
ABNX
Intraday Charts
Whats New @
Bazaartrend
ABNX
Free Analysis
 
ABNX Important Levels Intraday
RESISTANCE1.36
RESISTANCE1.32
RESISTANCE1.29
RESISTANCE1.27
SUPPORT1.19
SUPPORT1.17
SUPPORT1.14
SUPPORT1.10
 
ABNX Forecast May 2024
4th UP Forecast3.31
3rd UP Forecast2.64
2nd UP Forecast2.23
1st UP Forecast1.82
1st DOWN Forecast0.64
2nd DOWN Forecast0.23
3rd DOWN Forecast-0.18
4th DOWN Forecast-0.85
 
ABNX Weekly Forecast
4th UP Forecast2.19
3rd UP Forecast1.88
2nd UP Forecast1.69
1st UP Forecast1.50
1st DOWN Forecast0.96
2nd DOWN Forecast0.77
3rd DOWN Forecast0.58
4th DOWN Forecast0.27
 
ABNX Forecast2024
4th UP Forecast5.97
3rd UP Forecast4.45
2nd UP Forecast3.51
1st UP Forecast2.57
1st DOWN Forecast-0.11
2nd DOWN Forecast-1.05
3rd DOWN Forecast-1.99
4th DOWN Forecast-3.51
 
 
ABNX Other Details
Segment EQ
Market Capital 36503864.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ABNX Address
ABNX
 
ABNX Latest News
 
Your Comments and Response on ABIONYX Pharma SA
 
ABNX Business Profile
ABIONYX Pharma SA, a biopharmaceutical company, discovers and develops high density lipoprotein (HDL) therapies for the treatment of cardiovascular and metabolic diseases. The company is developing a portfolio of HDL therapies, which include HDL mimetics for the rapid regression of atherosclerotic plaque in high-risk patients. It is developing CER-001, an engineered complex of recombinant human apoA-I, the structural protein of HDL, and phospholipids that is in Phase II clinical trials designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; and CER-209, a drug candidate that is in Phase I clinical trial for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is based in Labege, France. Address: 33-43 av. Georges Pompidou ? Bât. D2, Labege, France, 31130
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service